Axplora- The partner of choice for complex APIs.
01 1Axplora
02 1Dr. Reddy's Laboratories
03 1Biophore India Pharmaceuticals Pvt Ltd
04 1LGM Pharma
05 1Aarti Pharmalabs
06 1Chongqing Sintaho Pharmaceutical
07 1Jinan Tantu Chemicals
08 1Tofigh Daru
09 1ALP Pharm
10 1Alembic Pharmaceuticals Limited
11 1Beijing Mesochem Technology
12 1Cambrex Corporation
13 1Cdymax
14 1Cipla
15 1Deva Holding AS
16 1Glenmark Life Sciences
17 1Haoyuan Chemexpress Co.Ltd
18 1Hetero Drugs
19 2MSN Laboratories
20 1Mac-Chem Products (India) Pvt.Ltd
21 1Morepen Laboratories
22 1Olon S.p.A
23 1Parsian Pharamceutical
24 1ScinoPharm Taiwan, Ltd
25 1Shandong Anhong Pharmaceutical
26 1Shandong Boyuan Pharmaceutical
27 1Shanghai Hope Chem
28 1Sun-shine Chem
29 1Wisdom Pharmaceutical
01 10China
02 1Germany
03 12India
04 2Iran
05 1Italy
06 1Taiwan
07 1Turkey
08 2U.S.A
01 13Active
02 17Blank
01 30Blank
01 30Blank
01 1WC-0082
02 1WC-0349
03 1WC-0349A12
04 27Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-04-19
Pay. Date : 2022-03-31
DMF Number : 35742
Submission : 2021-03-30
Status : Active
Type : II
NDC Package Code : 71796-034
Start Marketing Date : 2021-11-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40467
Submission : 2024-09-28
Status : Active
Type : II
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
Jinan Tantu Chemicals offers customized R&D services & production of small molecule APIs & pharmaceutical intermediates.
Tofigh Daru develops & synthesizes a diverse range of APIs in Anticancer, Narcotics, Cardiovascular to Immunomodulatory Segments.
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-07-10
Pay. Date : 2023-06-08
DMF Number : 38395
Submission : 2023-06-18
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38957
Submission : 2023-09-28
Status : Active
Type : II
We have 29 companies offering Olaparib
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?